TROP2: A Target for Cisplatin-Resistant Germ Cell Tumors
Recent studies have highlighted the complexities and challenges in treating germ cell tumors, particularly those that exhibit resistance to standard ...
Tag: targeted therapy
Case Study: Significant Tumor Response in Non-Small Cell Lung Cancer with SMARCA4 Deficiency and Rare EGFR Mutations Following Afatinib Treatment
Lung cancer remains a leading cause of cancer-related mortality worldwide, with various subtypes exhibiting unique molecular characteristics and treatment responses. ...
Single Dose Drug Candidate Successfully Eradicates Breast Cancer Tumors in Mouse Models
Breast cancer continues to be one of the most formidable challenges in oncology, claiming the lives of countless women and ...
Osimertinib Resistance and EGFR Mutations in NSCLC Treatment
The presence of the T790M mutation during first or second-generation EGFR-TKI treatments is observed in 50-60% of patients. This mutation ...
Advances in NSCLC Treatment – Overcoming Osimertinib Resistance and Exploring the Potential of Amivantamab and Lazertinib
In the ever-evolving landscape of cancer treatment, recent breakthroughs in the fight against non-small cell lung cancer (NSCLC) have brought ...
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps
-
ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy
-
New Study Suggests ALS and MS May Stem from Common Environmental Factor